mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 30 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 68.0% | 4.3 / 15.9 | 25 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 1,379,045 | 0 | T | G | 64.7% | 4.0 / 13.6 | 17 | G224G (GGT→GGG) | ycjX | YcjX family protein |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 64.0% | ‑0.9 / 17.8 | 25 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 2,336,785 | 0 | A | C | 60.0% | 9.3 / 19.6 | 20 | G288G (GGT→GGG) | yfaL | AIDA‑I family autotransporter adhesin YfaL/EhaC |
| * | NZ_CP009273 | 3,291,076 | 0 | A | C | 58.8% | 3.2 / 13.4 | 17 | V141G (GTG→GGG) | yraQ | permease |
| * | NZ_CP009273 | 3,806,452 | 0 | T | C | 58.8% | 5.2 / 13.2 | 17 | L121P (CTC→CCC) | coaBC | bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate‑‑cysteine ligase CoaBC |
| * | NZ_CP009273 | 1,235,279 | 0 | T | G | 58.3% | 3.4 / 10.1 | 12 | G315G (GGT→GGG) | dadX | catabolic alanine racemase DadX |
| * | NZ_CP009273 | 4,292,475 | 0 | T | G | 56.5% | 26.1 / 28.0 | 23 | T141P (ACC→CCC) | mdtO | multidrug efflux transporter permease subunit MdtO |
| * | NZ_CP009273 | 3,291,063 | 0 | A | C | 55.6% | 16.1 / 20.9 | 18 | G145G (GGT→GGG) | yraQ | permease |
| * | NZ_CP009273 | 937,169 | 0 | T | G | 55.0% | 5.6 / 24.5 | 20 | V252G (GTG→GGG) | dmsA | dimethylsulfoxide reductase subunit A |
| * | NZ_CP009273 | 68,027 | 0 | A | G | 54.5% | 6.1 / 11.2 | 11 | I64V (ATT→GTT) | yabI | DedA family protein |
| * | NZ_CP009273 | 262,078 | 0 | A | G | 54.5% | 9.8 / 12.7 | 11 | S63P (TCC→CCC) | BW25113_RS25425 | hypothetical protein |
| * | NZ_CP009273 | 585,390 | 0 | T | G | 54.5% | ‑0.9 / 11.9 | 11 | T341P (ACC→CCC) | nfrA | bacteriophage adsorption protein NfrA |
| * | NZ_CP009273 | 585,395 | 0 | A | G | 54.5% | 6.3 / 12.4 | 11 | L339P (CTC→CCC) | nfrA | bacteriophage adsorption protein NfrA |
| * | NZ_CP009273 | 2,331,202 | 0 | A | C | 54.5% | 7.3 / 11.0 | 11 | G566G (GGT→GGG) | gyrA | DNA topoisomerase (ATP‑hydrolyzing) subunit A |
| * | NZ_CP009273 | 2,436,061 | 0 | T | G | 54.5% | 7.1 / 11.6 | 11 | G273G (GGT→GGG) | mnmC | bifunctional tRNA (5‑methylaminomethyl‑2‑thiouridine)(34)‑methyltransferase MnmD/FAD‑dependent 5‑carboxymethylaminomethyl‑2‑thiouridine(34) oxidoreductase MnmC |
| * | NZ_CP009273 | 3,737,017 | 0 | A | C | 54.5% | 1.2 / 10.7 | 11 | T309P (ACC→CCC) | yiaK | 3‑dehydro‑L‑gulonate 2‑dehydrogenase |
| * | NZ_CP009273 | 4,026,091 | 0 | T | G | 54.5% | 9.0 / 12.6 | 11 | G80G (GGT→GGG) | yigZ | IMPACT family protein |
| * | NZ_CP009273 | 4,571,940 | 0 | A | C | 54.5% | 7.6 / 10.7 | 11 | V309G (GTG→GGG) | hsdM | type I restriction‑modification system methyltransferase |
| * | NZ_CP009273 | 646,265 | 0 | T | G | 53.8% | 6.2 / 15.4 | 13 | T350P (ACC→CCC) | citC | [citrate (pro‑3S)‑lyase] ligase |